We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
(+11%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$141M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$96.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Prologis
PLD
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$56.3M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$36M |
| 3 |
Y
Alleghany Corp
Y
|
+$33M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$26.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
FVCBankcorp
FVCB
$333M
| $341K | ﹤0.01% |
22,328
+314
| +1% | +$4.94K |
|
2627
Preformed Line Products
PLPC
$2.28B
| $341K | ﹤0.01% |
4,090
+64
| +2% | +$5.28K |
|
2628
Coupang
CPNG
$29.2B
| $340K | ﹤0.01% |
+23,109
| New | +$408K |
|
2629
GrowGeneration
GRWG
$90.7M
| $338K | ﹤0.01% |
86,245
+1,737
| +2% | +$8.28K |
|
2630
Janux Therapeutics
JANX
$967M
| $338K | ﹤0.01% |
25,691
+111
| +0.4% | +$1.63K |
|
2631
MVB Financial
MVBF
$389M
| $338K | ﹤0.01% |
15,353
-4
| -0% | -$98 |
|
2632
First Western Financial
MYFW
$306M
| $338K | ﹤0.01% |
12,003
+65
| +0.5% | +$1.81K |
|
2633
Karyopharm Therapeutics
KPTI
$48M
| $336K | ﹤0.01% |
6,583
-66
| -1% | -$4.58K |
|
|
HLTH
2634
DELISTED
Cue Health Inc. Common Stock
HLTH
| $336K | ﹤0.01% |
162,504
+1,158
| +0.7% | +$3.66K |
|
2635
Nuvation Bio
NUVB
$2.32B
| $335K | ﹤0.01% |
174,329
+2,499
| +1% | +$5.06K |
|
2636
Monte Rosa Therapeutics
GLUE
$1.35B
| $334K | ﹤0.01% |
43,849
+887
| +2% | +$7.39K |
|
2637
Regional Management Corp
RM
$303M
| $334K | ﹤0.01% |
11,907
-236
| -2% | -$6.95K |
|
2638
Capital Bancorp
CBNK
$615M
| $332K | ﹤0.01% |
14,117
+171
| +1% | +$4.13K |
|
2639
Heron Therapeutics
HRTX
$92.9M
| $332K | ﹤0.01% |
132,887
+3,628
| +3% | +$11.7K |
|
2640
Smartbird Inc
BIRD
$22.3M
| $331K | ﹤0.01% |
6,833
+171
| +3% | +$10K |
|
2641
Blue Ridge Bankshares
BRBS
$332M
| $331K | ﹤0.01% |
26,516
+10
| +0% | +$129 |
|
2642
Citi Trends
CTRN
$605M
| $330K | ﹤0.01% |
12,476
-276
| -2% | -$6.49K |
|
|
CMBM
2643
DELISTED
Cambium Networks
CMBM
| $329K | ﹤0.01% |
15,161
+422
| +3% | +$8.51K |
|
2644
RxSight
RXST
$260M
| $328K | ﹤0.01% |
25,920
+567
| +2% | +$6.9K |
|
2645
Evolv Technologies
EVLV
$1.1B
| $327K | ﹤0.01% |
126,306
-255
| -0.2% | -$751 |
|
2646
Rigel Pharmaceuticals
RIGL
$750M
| $327K | ﹤0.01% |
21,827
+527
| +2% | +$4.83K |
|
2647
Village Super Market
VLGEA
$639M
| $327K | ﹤0.01% |
14,057
+227
| +2% | +$5.04K |
|
|
WEBR
2648
DELISTED
Weber Inc.
WEBR
| $327K | ﹤0.01% |
40,617
+579
| +1% | +$4.04K |
|
2649
Universal Logistics Holdings
ULH
$529M
| $326K | ﹤0.01% |
9,758
-22
| -0.2% | -$770 |
|
2650
IBEX
IBEX
$499M
| $324K | ﹤0.01% |
+13,044
| New | +$294K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.
- RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
- RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
- RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
- RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
- RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
- RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.